Clinical Outcomes About Heparin Surface Modified Aspheric Lens

NCT ID: NCT02026765

Last Updated: 2015-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to obverse the effect of this type lens in the same as traditional aspheric intraocular lens at the same time, whether can further improve the effects of operation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Heparin surface treatment lens can reduce inflammatory reaction.
2. Modified aspheric lens are more in line with human optical properties than the traditional aspheric lens.
3. To obverse the effect of this type lens in the same as traditional aspheric intraocular lens at the same time, whether can further improve the effects of operation.
4. After one day, one week, one month, three month follow-up,Key observation on the flare, the optical quality, contrast sensitivity and other parameters.Study the postoperative inflammatory reaction with test group lens,and the impact on the visual quality.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Heparin Surface Modified Aspheric Lens

Heparin Surface Modified Aspheric Lens

Group Type OTHER

heparin surface modified aspheric lens

Intervention Type DEVICE

the other eye implant heparin surface modified aspheric lens

traditional lens

traditional Aspheric lens

Group Type OTHER

traditional lens

Intervention Type DEVICE

A random eyes with traditional lens

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

traditional lens

A random eyes with traditional lens

Intervention Type DEVICE

heparin surface modified aspheric lens

the other eye implant heparin surface modified aspheric lens

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cataract patients

Exclusion Criteria

* Eyed patients
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wenzhou Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

A-Yong Yu

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

AYong Yu, MD. PhD.

Role: STUDY_DIRECTOR

Wenzhou Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Affiliated Eye hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5AT-6M

Identifier Type: -

Identifier Source: org_study_id